HealthcareNews

Eli Lilly's Mounjaro Misses Out on Dedicated Sleep Apnea Approval in Europe

10 days ago

In a significant development for the pharmaceutical industry, Eli Lilly's diabetes drug, Mounjaro, has been denied a separate label for the treatment of sleep apnea in Europe. This decision, announced recently, highlights the ongoing complexities within the regulatory landscape governing medical treatments and their approvals across different markets.

CVS Appoints Former UnitedHealth Executive as Aetna Struggles to Provide Guidance

2 months ago

In a recently announced strategic move, CVS Health has appointed a former executive from UnitedHealth Group to take the helm at Aetna, one of its key health insurance divisions. This announcement comes at a critical time for Aetna, which has been unable to issue guidance for its financial performance, amplifying concerns among investors and analysts regarding the company’s future performance in a competitive healthcare landscape.

CVS Health Dismisses CEO Karen Lynch, Appoints David Joyner as Successor

2 months ago

In a surprising turn of events within the healthcare retail giant CVS Health, the company has announced the immediate ousting of CEO Karen Lynch. This strategic leadership change comes amidst ongoing struggles as CVS attempts to navigate a complicated healthcare landscape marked by competition and significant shifts in consumer behavior.

Johnson & Johnson Surprises with Profit Surge Amid Strong Darzalex Sales

2 months ago

In a remarkable performance that outshined analysts' expectations, Johnson & Johnson reported a significant boost in profits driven largely by the impressive sales of its cancer treatment drug, Darzalex. The healthcare giant has proven its resilience amid a competitive market landscape, showcasing not only strong product demand but also strategic management of its resources.

Sun Capital-Backed Medical Centers Enter Chapter 11 Amid Sale Pursuit

2 months ago

In a significant turn of events, a group of medical centers backed by Sun Capital Partners have filed for Chapter 11 bankruptcy protection. This strategic move is part of a broader plan to sell the distressed assets in hopes of revitalizing operations under new ownership. The centers, facing financial difficulties exacerbated by declining patient volumes and rising operational costs, aim to attract buyers through this reorganization process.